Active Ingredient (In Each Spray)
Naloxone hydrochloride 4 mg
The following Structured Product Label (SPL) was submitted to the FDA by Actavis Pharma, Inc. for the product Naloxone Hydrochloride (NDC 0591-3871). This document serves as the official prescribing information, containing essential scientific data and clinical materials required for healthcare providers and patients.
This specific version of the label includes detailed information regarding active ingredient (in each spray), purpose, uses, directions, warning, other information, inactive ingredients, questions?, and other regulatory disclosures. Use the navigation below to review specific sections of the FDA submission.
Naloxone hydrochloride 4 mg
Emergency treatment
of opioid overdose
Step 1: CHECK if you suspect an overdose:
| |
Step 2: GIVE 1stdose in the nose
| |
Step 3: CALL
| |
Step 4: WATCH & GIVE
| |
Step 5: STAY
|
benzalkonium chloride, edetate disodium, sodium chloride
buffered with sodium hydroxide/hydrochloric acid, water
1-888-838-2872 between 9 am and 5 pm ET, Monday-Friday.
www.tevausa.com/our-products/tevagenerics
NOT FOR RESALE
FOR NON-RETAIL
DISTRIBUTION
Compare to the active
ingredient in NARCAN®*
NDC 0591-3871-99
Naloxone Hydrochloride
Nasal Spray
4mg
Emergency Treatment of
Opioid Overdose
Designed to Rapidly Reverse the
Effects of a Life-Threatening
Opioid Emergency
For use in nose only
2 Single-Dose Nasal Spray Devices
0.003 fl oz (0.1 mL) each
* Please review the disclaimer below.